News & Updates
Filter by Specialty:
SC infliximab dose escalation restores efficacy, elicits rapid response in IBD
A retrospective analysis has shown that increasing the dose of subcutaneous infliximab (CT-P13 SC) from 120 to 240 mg Q2W in patients with inflammatory bowel disease who initially responded but subsequently lost response leads to improved clinical efficacy over an extended period.
SC infliximab dose escalation restores efficacy, elicits rapid response in IBD
24 Feb 2025
Long-term colchicine use helps prevent stroke, cardiac events
Treatment with colchicine appears to lower the risk of stroke and major adverse cardiovascular events (MACE) when used for longer duration, according to a study presented at ISC 2025. This beneficial effect, however, is not observed among patients with shorter follow-up duration.
Long-term colchicine use helps prevent stroke, cardiac events
23 Feb 2025
Postpartum diuretics use eases persistent hypertension
The postpartum use of diuretics can reduce persistent hypertension in women with hypertensive disorders of pregnancy (HDP), according to the results of a systematic review and meta-analysis presented at SMFM 2025.
Postpartum diuretics use eases persistent hypertension
20 Feb 2025
SGLT-2is, GLP-1RAs cut risk of COPD flare-ups
In adults with type 2 diabetes and active chronic obstructive pulmonary disease (COPD), sodium-glucose cotransporter-2 inhibitors (SGLT-2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) may also reduce the risk of COPD exacerbations, according to a study.